![]() |
||||||||||||||||||||||||||||
|
|
INTERCEPT Blood System for Plasma Although bacterial contamination is not common for plasma, studies performed using representative gram-negative and gram-positive organisms demonstrated efficacy of the INTERCEPT process for bacterial inactivation. In addition, studies demonstrated inactivation of two spirochete bacteria, Treponema pallidum, for which blood is currently tested, and Borrelia burgdorferi. Studies were carried out with these organisms because they are known to be asymptomatically present in the blood during chronic infections. Bacteria, which have been shown to be inactivated, are listed below:
|
|||||||||||||||||||||||||||
![]() |
©
Cerus Corporation. All Rights Reserved. Use of the INTERCEPT Blood System in the United States is limited by Federal law to investigational use. If you are a resident of the U.S., please click here. The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located. The INTERCEPT Blood System is CE marked for use with platelets and plasma. Website design by NetPilot Web Solutions |
|||||||||||||||||||||||||||